ALGS · Aligos Therapeutics, Inc.
$4.34
+0.09 (+2.00%)
At close · Jul 30
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our recurring losses from operations and negative cash flows have raised substantial doubt regarding our ability to continue as a going concern”View the 10-Q filed May 7, 2026
Market Cap
$15.25M
Shares
3.59M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.